TG Therapeutics Inc (NASDAQ:TGTX)
| 15.62 Delayed Data As of Feb 21 |  -0.20 / -1.26%Today’s Change | 4.58 Today|||52-Week Range 16.22 | +40.72% Year-to-Date |
Latest TGTX News | Press Releases
| 2 Top Stocks Under $20 Feb 15 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.82 |
| Today’s open | 15.77 |
| Day’s range | 15.27 - 15.77 |
| Volume | 1,822,337 |
| Average volume (3 months) | 1,937,118 |
| Market cap | $1.6B |
Data as of 3:59pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | -20.36% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -0.25% |
| P/E ratio | NM |
| Price/Sales | 2,035.62 |
| Price/Book | 54.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CORTCorcept Therapeutics... | -0.07 | -0.51% |
| INVAInnoviva Inc | +0.02 | +0.13% |
| ---- | ||
| TBPHTheravance Biopharma... | -0.13 | -0.50% |
Data as of 4:15pm ET, 02/21/2020
Financials
| Next reporting date | March 5, 2020 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $152.0K |
| Annual profit (last year) | -$173.5M |
| Net profit margin | -114,132.89% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
